Impact of biochemical recurrence in prostate cancer among US veterans.
about
Low-dose rate brachytherapy for men with localized prostate cancer'Race' and prostate cancer mortality in equal-access healthcare systemsMetabolomic profiling of hormone-dependent cancers: a bird's eye viewEffect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studiesValidation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence.A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination.Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer.Cabazitaxel (jevtana): a novel agent for metastatic castration-resistant prostate cancerDietary fatty acid intake and prostate cancer survival in Örebro County, Sweden.The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: results from a population-based cohort.A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancerProstate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.Sipuleucel-T for the treatment of metastatic prostate cancer: promise and challenges.Castration-resistant metastatic prostate cancer: current status and treatment possibilities.The FHL2 regulation in the transcriptional circuitry of human cancers.Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer.Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy.A Placebo-Controlled Double-Blinded Randomized Pilot Study of Combination Phytotherapy in Biochemically Recurrent Prostate Cancer.68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CTPrediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results.Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.Safety and efficacy of salvage low-dose-rate brachytherapy for prostate bed recurrences following radical prostatectomy.The changing landscape of treatment options for metastatic castrate-resistant prostate cancer: challenges and solutions for physicians and patients.Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy.Prostate cancer survivorship care in the Veterans Health Administration
P2860
Q24235544-FE58EA01-0D7B-4DA2-AFFD-63B33025D54AQ27008227-C4AFB3D1-CADE-47F5-B297-4F6BBE45C6BDQ28084834-910CECC2-338D-411D-8126-A47202789C02Q28542914-8204DA89-5F72-4BD5-8DBA-2707E446D665Q30582750-85EABF99-5FB3-48CB-890C-8F9F2B52956CQ33465128-9014FDD4-3CC7-47FB-994A-C0302455AD5BQ33898869-B56B8E21-8183-4C2B-A49C-4651EDBF0975Q34712333-44CD5151-0A96-4A80-85D1-E5DB6065FEE9Q36327344-266786D5-BD87-4670-9B2A-B317E6B86A34Q36379958-111FFE83-0BD7-45A3-A239-0490C319B7A8Q36398860-518E0A8E-1D91-4728-8C7F-6D9D35CC62FFQ36546241-A761F75B-C3F8-4D84-85CE-8FE2DFB6313BQ37390674-AF84440F-A40F-4F85-A55A-BF4239336761Q37984189-90CA7679-616D-4166-A010-827B9E0381A0Q37989075-F07CE4E7-7A2D-4C7E-B968-CD4481E221BCQ38554494-2AC097F2-F9CE-4AFD-9555-77AAD10BB881Q38615085-8B42D824-F138-4C4C-8715-C2480B6DE115Q38804450-354C784C-9A48-44AB-957C-4E0746154A55Q38970207-704AA84B-07B8-4F28-996F-24FF56686433Q39922053-C88BE698-A610-4DAE-B639-92136A0FBF09Q40330198-FEA9B70A-6110-4DD1-A5D0-42EA01AC2A1CQ40674443-99802FA8-CDBA-4B80-AD53-097C5C4361E6Q41914001-C14164BC-CE29-40CC-ACA4-0B0172D65DE7Q42417359-B4413BAD-F42B-46D6-B3A2-424067CF13D4Q44048933-1DC117CC-610A-4FAF-9299-8B723A0F6DD6Q58134906-6A97EDC5-57E3-4D2D-99B9-B3A4AF6BA7BA
P2860
Impact of biochemical recurrence in prostate cancer among US veterans.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Impact of biochemical recurrence in prostate cancer among US veterans.
@ast
Impact of biochemical recurrence in prostate cancer among US veterans.
@en
Impact of biochemical recurrence in prostate cancer among US veterans.
@nl
type
label
Impact of biochemical recurrence in prostate cancer among US veterans.
@ast
Impact of biochemical recurrence in prostate cancer among US veterans.
@en
Impact of biochemical recurrence in prostate cancer among US veterans.
@nl
prefLabel
Impact of biochemical recurrence in prostate cancer among US veterans.
@ast
Impact of biochemical recurrence in prostate cancer among US veterans.
@en
Impact of biochemical recurrence in prostate cancer among US veterans.
@nl
P2093
P1476
Impact of biochemical recurrence in prostate cancer among US veterans.
@en
P2093
Carolyn K Wells
Edward M Uchio
John Concato
Juan Calderone
Mihaela Aslan
P304
P356
10.1001/ARCHINTERNMED.2010.262
P407
P577
2010-08-01T00:00:00Z